Actelion Pharmaceuticals Ltd – Strategy, SWOT and Corporate Finance Report

Actelion Pharmaceuticals Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Actelion Pharmaceuticals Ltd. (Actelion or 'the company'), a subsidiary of Johnson & Johnson, is a biopharmaceutical company focused on the discovery, development and commercialization of low molecular weight drugs to address high unmet medical needs. The company's business is primarily focused on discovery, development and commercialization of innovative medicines for unmet medical needs. It offers variety of drugs for the treatment of cardiovascular disorders, infectious diseases, cancer, central nervous system disorders, and immunological disorders. The company has its operations in North and South America, Europe and Asia Pacific. The company is headquartered in Allschwil, Switzerland.

Scope

– Detailed information on Actelion Pharmaceuticals Ltd required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Actelion Pharmaceuticals Ltd in the form of a SWOT analysis

– An in-depth view of the business model of Actelion Pharmaceuticals Ltd including a breakdown and examination of key business segments

– Intelligence on Actelion Pharmaceuticals Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Actelion Pharmaceuticals Ltd, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Actelion Pharmaceuticals Ltd and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Actelion Pharmaceuticals Ltd as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Actelion Pharmaceuticals Ltd's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Actelion Pharmaceuticals Ltd: Company Overview

Actelion Pharmaceuticals Ltd: Overview and Key Facts

Actelion Pharmaceuticals Ltd: Overview

Actelion Pharmaceuticals Ltd: Key Facts

Actelion Pharmaceuticals Ltd: Key Employees

Actelion Pharmaceuticals Ltd: Key Employee Biographies

Actelion Pharmaceuticals Ltd: Major Products and Services

Actelion Pharmaceuticals Ltd: Company History

Actelion Pharmaceuticals Ltd: Locations and Subsidiaries

Actelion Pharmaceuticals Ltd: Key Competitors

Actelion Pharmaceuticals Ltd: Company Analysis

Actelion Pharmaceuticals Ltd: Business Description

Actelion Pharmaceuticals Ltd: SWOT Analysis

Actelion Pharmaceuticals Ltd: SWOT Overview

Actelion Pharmaceuticals Ltd: Strengths

Actelion Pharmaceuticals Ltd: Weaknesses

Actelion Pharmaceuticals Ltd: Opportunities

Actelion Pharmaceuticals Ltd: Threats

Actelion Pharmaceuticals Ltd: Corporate Financial Deals Activity

Actelion Pharmaceuticals Ltd: Financial Deals Overview

Actelion Pharmaceuticals Ltd: Targets and Partners

Actelion Pharmaceuticals Ltd: Top Deals 2016 - 2020YTD*

Actelion Pharmaceuticals Ltd: Advisors

Actelion Pharmaceuticals Ltd: Top Legal Advisors

Actelion Pharmaceuticals Ltd: Top Financial Advisors

Actelion Pharmaceuticals Ltd: Partnership

Actelion Pharmaceuticals Ltd: Divestments

Actelion Pharmaceuticals Ltd: Private Equity and Ownership

Actelion Pharmaceuticals Ltd: Recent Developments

Actelion Pharmaceuticals Ltd: News and Events Summary

Actelion Pharmaceuticals Ltd: Business Expansion

Actelion Pharmaceuticals Ltd: Corporate Governance

Actelion Pharmaceuticals Ltd: Financial Performance

Actelion Pharmaceuticals Ltd: Regulatory and Legal Events

Actelion Pharmaceuticals Ltd: Research & Development

Actelion Pharmaceuticals Ltd: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Actelion Pharmaceuticals Ltd: Key Facts

Table 2: Actelion Pharmaceuticals Ltd: Key Employees

Table 3: Actelion Pharmaceuticals Ltd: Company History

Table 4: Actelion Pharmaceuticals Ltd: Locations and Subsidiaries

Table 5: Actelion Pharmaceuticals Ltd: Key Competitors

Table 6: Actelion Pharmaceuticals Ltd: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Table 7: Actelion Pharmaceuticals Ltd: Targets and Partners

Table 8: Actelion Pharmaceuticals Ltd: Top Deals 2016 – 2020YTD*

Table 9: Actelion Pharmaceuticals Ltd: Legal Advisor Ranking by Value (US$m)

Table 10: Actelion Pharmaceuticals Ltd: Financial Advisor Ranking by Value (US$m)

Table 11: Actelion Pharmaceuticals Ltd: Partnership Volume and Value Trend (2016 – YTD*2020)

Table 12: Actelion Pharmaceuticals Ltd: Partnership Trend by Deal Type (2016 – YTD*2020)

Table 13: Actelion Pharmaceuticals Ltd: Divestments Volume and Value Trend (2016 – YTD*2020)

Table 14: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume and Value Trend (2016 – YTD*2020)

Table 15: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume by Deal Type (2016 – YTD*2020)

Table 16: Actelion Pharmaceuticals Ltd: News and Events Summary

Table 17: Actelion Pharmaceuticals Ltd: Business Expansion

Table 18: Actelion Pharmaceuticals Ltd: Corporate Governance

Table 19: Actelion Pharmaceuticals Ltd: Financial Performance

Table 20: Actelion Pharmaceuticals Ltd: Regulatory and Legal Events

Table 21: Actelion Pharmaceuticals Ltd: Research & Development

Table 22: Actelion Pharmaceuticals Ltd: Strategy and Operations

List of Figures

List of Figures

Figure 1: Actelion Pharmaceuticals Ltd: Deal Activity by Deal Type – Volume (2016 – YTD*2020)

Figure 2: Actelion Pharmaceuticals Ltd: Partnership Volume and Value Trend (2016 – YTD*2020)

Figure 3: Actelion Pharmaceuticals Ltd: Partnership Trend by Deal Type (2016 – YTD*2020)

Figure 4: Actelion Pharmaceuticals Ltd: Divestments Volume and Value Trend (2016 – YTD*2020)

Figure 5: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume and Value Trend (2016 – YTD*2020)

Figure 6: Actelion Pharmaceuticals Ltd: Private Equity and Ownership Volume by Deal Type (2016 – YTD*2020)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports